Beijing Sungen Biomedical Technology Co., Ltd

This study is testing an experimental drug called SGC001 in people who are having a major heart attack in the front of the heart. The goal is to see if the drug can reduce the amount of permanent heart muscle damage and lower the risk of future heart problems like heart failure o…